title: 21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancer.
authors.forename: B M
authors.initials: BM
authors.lastname: Cantwell
authors.forename: M J
authors.initials: MJ
authors.lastname: Millward
authors.forename: M J
authors.initials: MJ
authors.lastname: Lind
authors.forename: A H
authors.initials: AH
authors.lastname: Calvert
mesh_terms: D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004407:Dysgerminoma / Q000188:drug therapy* / Q000556:secondary; D005047:Etoposide / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D011379:Prognosis; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000556:secondary
chemical_list: D005047:Etoposide